Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharmacokinetics of ASP3652”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Early research (Phase 1)Study completedNCT02243657
What this trial is testing

Assess the Safety, Tolerability, and Effects in and on the Body of Healthy Young and Elderly Male and Female Subjects of Ascending Multiple Oral Doses of ASP3652

Who this might be right for
Healthy SubjectsPharmacokinetics of ASP3652Pharmacodynamics of ASP3652
Astellas Pharma Europe B.V. 101
Testing effectiveness (Phase 2)Study completedNCT01613586
What this trial is testing

Study Comparing Placebo and ASP3652 in the Treatment of Women With Bladder Pain Syndrome / Interstitial Cystitis (BPS/IC)

Who this might be right for
Cystitis, InterstitialUrinary Bladder DiseasePain+1 more
Astellas Pharma Europe B.V. 287
Early research (Phase 1)Study completedNCT02034734
What this trial is testing

Investigate the Appearance and Disappearance of ASP3652 in Blood and Spinal Fluid in Healthy Male Subjects

Who this might be right for
Pharmacokinetics of ASP3652Pharmacodynamics of ASP3652Healthy Subjects
Astellas Pharma Europe B.V. 14
Testing effectiveness (Phase 2)Study completedNCT01391338
What this trial is testing

A Clinical Study to Investigate the Efficacy, Safety and Pharmacokinetics of ASP3652 in Patients With Chronic Abacterial Prostatitis / Chronic Pelvic Pain Syndrome (CP/CPPS)

Who this might be right for
Chronic Abacterial ProstatitisChronic Pelvic Pain Syndrome
Astellas Pharma Inc 239
Early research (Phase 1)Study completedNCT02046798
What this trial is testing

Assess the Pharmacokinetics, Metabolism and Excretion Routes of ASP3652 in Man, After Administration of 14C Radio Labeled ASP3652

Who this might be right for
Healthy SubjectsPharmacokinetics of ASP3652
Astellas Pharma Europe B.V. 6
Early research (Phase 1)Study completedNCT01797198
What this trial is testing

Assess the Effect of Multiple Doses of Gemfribozil on a Single Dose of ASP3652, and to Assess the Effects of Multiple Doses of ASP3652 on a Single Dose of Repaglinide in the Body of Healthy Subjects

Who this might be right for
Drug-Drug Interaction (DDI)Healthy Subjects
Astellas Pharma Europe B.V. 48
Early research (Phase 1)Study completedNCT01815684
What this trial is testing

Assess the Safety, Tolerability and Effects of Single Ascending Doses of ASP3652 in Healthy Subjects

Who this might be right for
PharmacokineticsPharmacodynamicsHealthy Subjects+1 more
Astellas Pharma Europe B.V. 26
Early research (Phase 1)Study completedNCT01958047
What this trial is testing

Assess the Effect of Race on How a Single Dose of ASP3652 is Taken up, Metabolized and Distributed Through the Bodies of Young, Healthy Male and Female Subjects, and Its Safety and Tolerability

Who this might be right for
PharmacokineticsPharmacodynamicsHealthy Subjects+1 more
Astellas Pharma Europe B.V. 64